This preclinical study identifies novel histologic and proteomic targets that could help develop therapies against pulmonary vascular remodeling in heart failure-related pulmonary hypertension.
These findings provide new therapeutic targets to oppose pulmonary vascular remodeling in HF-related PH.
Fayyaz et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: